EUVIMEDEUVIMED entdecken
Crossref

Engaging in Patient and Public Involvement(PPI)

Ryoji Noritake

Iryo To Shakai · 14.07.2026 · 36 (1) · 19-30

DOI: 10.4091/iken.36-19 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iryo To Shakai, erschienen am 14.07.2026. Verfasst von Ryoji Noritake. Die Arbeit nennt 43 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This paper examines the theoretical foundations and practical implementation of Patient and Public Involvement(PPI)in health policy.The concept of patient participation has historical roots in social movements demanding self-determination: internationally, the disability rights movement and civil rights movement; in Japan, advocacy movements triggered by the HIV-tainted blood scandal and Hansen’s disease isolation policies. Theoretically, phenomenological concepts of “lived experience” articulated by Husserl and Merleau-Ponty, along with medical anthropology’s distinction between disease and illness proposed by Kleinman, establish the epistemological value of patients’ experiential knowledge. Efforts to incorporate subjective experiences such as pain and dermatological sensations into health policy represent practical applications of these theoretical perspectives.Internationally, institutionalization of patient participation has progressed through bodies such as NICE in the UK, G-BA in Germany, and EMA in Europe. In Japan, legislation including the Cancer Control Act(2006)has mandated stakeholder participation in disease-specific basic laws. However, structural challenges persist across countries: tokenism, representativeness bias, and fundamental questions about who constitutes a legitimate “stakeholder.”The Health and Global Policy Institute(HGPI)has evolved its approach through three initiatives: the Commission on Citizens and Health(2008-), NCD Alliance Japan (2013-), and J-PEP(2024-), progressively expanding from patient organization support to cross-disease collaboration and inclusion of individual patient leaders.This paper argues that genuine patient participation requires moving beyond rhetorical endorsement of the concept. Instead, we must engage with patient leaders as equal partners in candid, sometimes critical, dialogue.

Zitieren

APA

Noritake, R. (2026). Engaging in Patient and Public Involvement(PPI). Iryo To Shakai, 36(1), 19-30. https://doi.org/10.4091/iken.36-19

Vancouver

Noritake R. Engaging in Patient and Public Involvement(PPI). Iryo To Shakai. 2026;36(1):19-30. doi:10.4091/iken.36-19

BibTeX
@article{Noritake2026,
  author = {Noritake, Ryoji},
  title = {Engaging in Patient and Public Involvement(PPI)},
  journal = {Iryo To Shakai},
  year = {2026},
  volume = {36},
  number = {1},
  pages = {19--30},
  doi = {10.4091/iken.36-19}
}
Kostenlos starten →